By GPC Reporter
Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) plans to introduce bone marrow transplant services by March 2027, becoming the first public hospital in Kenya to offer the specialised procedure.
The hospital’s Acting Chief Executive Officer, Dr Joshua Clinton Okise, announced the plans during an interview on NTV’s Fixing the Nation, where he outlined JOOTRH’s transformation, achievements and future priorities following its elevation.
Also Read
Dr Okise said the hospital’s Comprehensive Cancer Centre was 85 per cent complete and expected to become operational by March 2027. The facility will incorporate bone marrow transplant services, expanding access to specialised treatment for cancer and blood-related conditions.
The planned service is expected to benefit patients with conditions such as sickle cell disease, who currently have limited access to bone marrow transplantation in Kenya. Patients seeking the procedure have often had to rely on a few private hospitals in Nairobi or travel abroad, incurring substantial medical and travel costs.
The development builds on JOOTRH’s investment in specialised sickle cell care, including apheresis services, which involve removing and replacing a patient’s red blood cells to reduce complications associated with the disease.
JOOTRH is currently the first public hospital in Kenya to offer apheresis services. Since their introduction, more than 80 children and adults have benefited from the treatment, improving access to specialised care in Kisumu County and the wider Lake Region.

Dr Okise said the hospital’s expanding range of specialised services was aimed at bringing advanced healthcare closer to patients and reducing referrals outside the region.
The services are also expected to ease the financial burden on families. Apheresis treatment is already covered under the Social Health Authority (SHA), while coverage for bone marrow transplantation will depend on the applicable benefits package and approval arrangements.
The interview offered patients, caregivers and hospital staff an opportunity to hear from the hospital’s leadership about progress made since its elevation and plans to strengthen its position as a specialised referral facility.
Once completed, the Comprehensive Cancer Centre is expected to expand JOOTRH’s capacity to provide advanced cancer care and other specialised treatments, potentially reducing the need for patients in the region to seek such services elsewhere.





